Equities

Enfusion Inc

ENFN:NYQ

Enfusion Inc

Actions
TechnologyTechnology
  • Price (USD)9.69
  • Today's Change0.19 / 2.00%
  • Shares traded599.11k
  • 1 Year change+1.57%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments366364
Total Receivables, Net282618
Total Inventory------
Prepaid expenses5.016.117.09
Other current assets, total1.172.30--
Total current assets709790
Property, plant & equipment, net332213
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets6.504.483.36
Total assets109124106
LIABILITIES
Accounts payable2.211.692.53
Accrued expenses18165.58
Notes payable/short-term debt000
Current portion long-term debt/capital leases----0
Other current liabilities, total----0
Total current liabilities20178.11
Total long term debt000
Total debt000
Deferred income tax------
Minority interest243842
Other liabilities, total112.960.54
Total liabilities555951
SHAREHOLDERS EQUITY
Common stock0.130.110.11
Additional paid-in capital227244227
Retained earnings (accumulated deficit)(173)(179)(171)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.41)(0.5)(0.33)
Total equity546555
Total liabilities & shareholders' equity109124106
Total common shares outstanding128114113
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.